April 01, 2020
HANGZHOU and SHAOXING, China, March 31, 2020 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) announces today that its partner Sagimet Biosciences (formerly 3-V Biosciences, Inc), will present clinical and preclinical data on non-alcoholic steatohepatitis (NASH) drug candidate...
Source URL: https://www.prnewswire.com:443/news-releases/data-on-nash-candidate-asc40-to-be-presented-at-easl-ilc-2020-301033040.html
|
